VMI
MNTA

VHCP Management II’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

VHCP Management II’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-262,822
Closed -$6.91M – 23
2018
Q3 		$6.91M Sell
262,822
-162,178
-38% -$4.38M 1.85% 13
2018
Q2 		$8.69M Hold
425,000
– – 2.6% 12
2018
Q1 		$7.71M Buy
+425,000
New +$7.09M 1.86% 14

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VHCP Management II's MNTA Position: Q4 2018 in Review

VHCP Management II sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2018, closing a stake of 262,822 shares — an estimated $6.91M sold.

VHCP Management II first reported a position in MNTA in Q1 2018 and held it in 3 quarters. The position peaked at $8.69M in Q2 2018. 158 funds tracked by Wall St. Rank hold MNTA as of Q4 2018.

  • VHCP Management II reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • VHCP Management II sold 262,822 Momenta Pharmaceuticals, Inc. shares in Q4 2018, an estimated $6.91M.
  • VHCP Management II first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 3 quarters.
  • VHCP Management II's Momenta Pharmaceuticals, Inc. position peaked at $8.69M in Q2 2018.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2018.

Based on VHCP Management II's 13F filing for Q4 2018, filed 13 Feb 2019.